corner
Healthy Skepticism
Join us to help reduce harm from misleading health information.
Increase font size   Decrease font size   Print-friendly view   Print
Register Log in

Healthy Skepticism Library item: 970

Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.

 

Publication type: news

BBC News.
GSK investors bring Paxil lawsuit
BBC News 2005 Apr 14


Full text:

GlaxoSmithKline (GSK) is facing a class action lawsuit in the US from investors who allege it concealed problems with its anti-depressant drug Paxil.
They allege the firm violated securities laws by issuing “false or misleading public statements”.

It comes after studies found Paxil could increase the risk of suicidal behaviour in adolescents.

GSK, which is also facing patient lawsuits over Paxil, said the allegations were “without merit”.

A spokesman for GSK, which in the past has defended the way it presented clinical research on Paxil, added that the company had not yet been served with a copy of the lawsuit.

US legal firm Schatz & Nobel said the case was filed on behalf of investors who bought GSK shares traded on the New York Stock Exchange between 21 February 2001 and 5 August 2004.

It claims Glaxo “improperly concealed deficiencies” with Paxil – which is also sold under the name Seroxat – in the treatment of adolescents.

The drug used to be GSK’s top-selling product but sales have slowed with the release of cheaper generic versions of the treatment.

 

  Healthy Skepticism on RSS   Healthy Skepticism on Facebook   Healthy Skepticism on Twitter

Please
Click to Register

(read more)

then
Click to Log in
for free access to more features of this website.

Forgot your username or password?

You are invited to
apply for membership
of Healthy Skepticism,
if you support our aims.

Pay a subscription

Support our work with a donation

Buy Healthy Skepticism T Shirts


If there is something you don't like, please tell us. If you like our work, please tell others.

Email a Friend








Cases of wilful misrepresentation are a rarity in medical advertising. For every advertisement in which nonexistent doctors are called on to testify or deliberately irrelevant references are bunched up in [fine print], you will find a hundred or more whose greatest offenses are unquestioning enthusiasm and the skill to communicate it.

The best defence the physician can muster against this kind of advertising is a healthy skepticism and a willingness, not always apparent in the past, to do his homework. He must cultivate a flair for spotting the logical loophole, the invalid clinical trial, the unreliable or meaningless testimonial, the unneeded improvement and the unlikely claim. Above all, he must develop greater resistance to the lure of the fashionable and the new.
- Pierre R. Garai (advertising executive) 1963